Mirae Asset Global ETFs Holdings
MCRB icon

Mirae Asset Global ETFs Holdings’s Seres Therapeutics MCRB Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,522
Closed -$36.5K – 3142
2024
Q2 		$36.5K Buy
+2,522
New +$42.1K ﹤0.01% 2851

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Schonfeld Strategic Advisors
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's MCRB Position: Q3 2024 in Review

Mirae Asset Global ETFs Holdings sold out of Seres Therapeutics (MCRB) in Q3 2024, closing a stake of 2,522 shares — an estimated $36.5K sold.

Mirae Asset Global ETFs Holdings first reported a position in MCRB in Q2 2024 and held it in 1 quarter. The position peaked at $36.5K in Q2 2024. 77 funds tracked by Wall St. Rank hold MCRB as of Q3 2024.

  • Mirae Asset Global ETFs Holdings reported no remaining Seres Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 2,522 Seres Therapeutics shares in Q3 2024, an estimated $36.5K.
  • Mirae Asset Global ETFs Holdings first reported a position in Seres Therapeutics in Q2 2024 and held it in 1 quarter.
  • Mirae Asset Global ETFs Holdings's Seres Therapeutics position peaked at $36.5K in Q2 2024.
  • 77 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2024.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.